Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.576NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.576NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.576NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.325NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.325NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.325NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.521NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.521NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.521NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.378NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.378NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.378NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.206NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.206NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.206NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.77NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.77NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.13.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.13.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.13.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BM.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BM.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBENUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBENYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBENChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.4.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.1.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used